Konstantinos D. Vassilakis

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

CRP at diagnosis in psoriatic arthritis: what it means and associations with long-term outcomes.

CRP at diagnosis in psoriatic arthritis: what it means and associations with long-term outcomes.

Journal: Rheumatology (Oxford, England)

Published: February 28, 2026

Enthesitis in Spondyloarthritis. From pathogenesis to clinical presentation and imaging: Similarities and differences between PsA and axSpA.

Enthesitis in Spondyloarthritis. From pathogenesis to clinical presentation and imaging: Similarities and differences between PsA and axSpA.

Journal: Autoimmunity reviews

Published: February 11, 2026

Glucocorticoid-induced diabetes mellitus: mechanisms, risk factors, and clinical pathways with insights from autoimmune rheumatic diseases.

Glucocorticoid-induced diabetes mellitus: mechanisms, risk factors, and clinical pathways with insights from autoimmune rheumatic diseases.

Journal: Rheumatology international

Published: January 23, 2026

Cycling or Swapping in Spondyloarthritis? Current Knowledge.

Cycling or Swapping in Spondyloarthritis? Current Knowledge.

Journal: Mediterranean journal of rheumatology

Published: October 04, 2025

Late-onset psoriatic arthritis: data from a nationwide cross-sectional study.

Late-onset psoriatic arthritis: data from a nationwide cross-sectional study.

Journal: Therapeutic advances in musculoskeletal disease

Published: July 17, 2025

Antiobesity medications in rheumatology. Quo vadis?

Antiobesity medications in rheumatology. Quo vadis?

Journal: Annals of the rheumatic diseases

Published: June 30, 2025

Skin cancer in inflammatory arthritis: should we advise screening?

Skin cancer in inflammatory arthritis: should we advise screening?

Journal: The Lancet. Rheumatology

Published: June 18, 2025

Combination targeted therapy with two biologic/targeted synthetic DMARDs in 1200 patients with immune mediated inflammatory diseases. A systematic literature review for current landscape in safety and efficacy.

Combination targeted therapy with two biologic/targeted synthetic DMARDs in 1200 patients with immune mediated inflammatory diseases. A systematic literature review for current landscape in safety and efficacy.

Journal: Autoimmunity reviews

Published: June 16, 2025

HCV Reactivation Risk in Patients Undergoing Treatment for Inflammatory Arthritis and Connective Tissue Diseases.

HCV Reactivation Risk in Patients Undergoing Treatment for Inflammatory Arthritis and Connective Tissue Diseases.

Journal: Mediterranean journal of rheumatology

Published: April 03, 2025

Identification and characteristics of patients with axial psoriatic arthritis: clinical, phenotypic and imaging associations.

Identification and characteristics of patients with axial psoriatic arthritis: clinical, phenotypic and imaging associations.

Journal: Rheumatology (Oxford, England)

Published: December 16, 2024

Comment on: 'Hepatitis B reactivation in PsA patients: an SLR and meta-analysis for IL-17, IL-23 and JAK inhibitors': reply.

Comment on: 'Hepatitis B reactivation in PsA patients: an SLR and meta-analysis for IL-17, IL-23 and JAK inhibitors': reply.

Journal: Rheumatology (Oxford, England)

Published: November 13, 2024

Difficult to Treat Psoriatic Arthritis: The Road So Far.

Difficult to Treat Psoriatic Arthritis: The Road So Far.

Journal: Mediterranean journal of rheumatology

Published: June 25, 2024

Showing 1-12 of 16

Last Updated: 09/26/2026